12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B
Key Takeaways
- Phytonadione 1.0 mg intramuscularly into the vastus lateralis within 6 hours of birth prevents early, classic, and late vitamin K deficiency bleeding.
- Late vitamin K deficiency bleeding occurs almost exclusively in exclusively breastfed infants who did not receive parenteral prophylaxis, and more than half of cases present as intracranial hemorrhage.
- Oral vitamin K regimens are not FDA-approved, absorb erratically, and fail to reliably prevent late vitamin K deficiency bleeding.
- Erythromycin ophthalmic ointment prevents gonococcal ophthalmia but does not prevent chlamydial conjunctivitis, which appears at 5 to 14 days and requires systemic macrolide therapy.
- An infant born to an HBsAg-positive mother receives hepatitis B vaccine plus HBIG within 12 hours at two separate sites, preventing transmission in more than 95 percent of exposures.
The neonatal period encompasses vital preventive interventions and universal screening programs designed to intercept life-threatening disorders before irreversible injury occurs. The certified nurse-midwife (CNM) plays an indispensable role in administering routine pharmacologic prophylaxis, interpreting multi-tiered universal screening panels, counseling families on evidence-based care, and managing common metabolic and hematologic derangements. On the AMCB certification examination, candidates are tested rigorously on the pathogenesis of Vitamin K Deficiency Bleeding (VKDB), the Critical Congenital Heart Disease (CCHD) pulse oximetry algorithm, blood spot metabolic panels, the management of neonatal hypoglycemia, and the differential diagnosis and phototherapy thresholds for neonatal hyperbilirubinemia.
Standard Neonatal Prophylaxis
Within the first hours following delivery, every newborn should receive three standardized prophylactic interventions: parenteral vitamin K1, ophthalmic antibiotic ointment, and the initial hepatitis B immunization.
Standard Post-Delivery Prophylaxis Bundle
├── 1. Vitamin K1 (Phytonadione) ──> 1 mg IM within 6 hr ──> Prevents Early, Classic & Late VKDB
├── 2. Erythromycin 0.5% Ointment ──> 1 cm ribbon each eye ──> Prevents Neisseria gonorrhoeae Ophthalmia
└── 3. Hepatitis B Vaccine ──> 5 mcg IM within 24 hr ──> + HBIG within 12 hr if maternal HBsAg positive
1. Vitamin K1 (Phytonadione) Prophylaxis
- Physiologic Rationale: Neonates are born functionally deficient in vitamin K. Placentally transferred vitamin K is minimal, the sterile neonatal intestinal tract lacks colonizing microflora capable of synthesizing menaquinones, and breast milk contains very low concentrations (1 to 3 mcg/L, compared to infant requirements of ~1 mcg/kg/day). Vitamin K is an essential cofactor for hepatic gamma-glutamyl carboxylase, which catalyzes the post-translational carboxylation of glutamic acid residues required for functional activation of clotting factors II (prothrombin), VII, IX, and X, as well as regulatory proteins C and S.
- Dosing & Route: Phytonadione 1.0 mg Intramuscularly (IM) (0.5 mg IM for preterm infants <1,500 g) administered into the anterolateral thigh (vastus lateralis) within 6 hours of birth.
- Vitamin K Deficiency Bleeding (VKDB) Syndromes:
- Early VKDB (First 24 hours): Occurs in infants whose mothers took medications that interfere with vitamin K metabolism (e.g., anticonvulsants such as phenytoin, carbamazepine, phenobarbital; rifampin; isoniazid; or maternal warfarin). Presents with severe cephalic, intrathoracic, or intra-abdominal bleeding.
- Classic VKDB (Days 2 to 7): Associated with delayed feeding or suboptimal intake. Presents with cutaneous bruising, gastrointestinal bleeding, persistent oozing from the umbilical cord stump, or prolonged bleeding following circumcision.
- Late VKDB (Weeks 2 to 12, up to 6 months): Occurs almost exclusively in exclusively breastfed infants who did NOT receive parenteral vitamin K prophylaxis at birth. Over 50% of late VKDB cases manifest as catastrophic intracranial hemorrhage (ICH), carrying a 20% mortality rate and leaving surviving infants with profound, permanent neurologic deficits.
- Oral Vitamin K Limitations: Oral vitamin K regimens are NOT FDA-approved, have erratic gastrointestinal absorption, require strict multi-dose adherence over weeks, and fail to reliably prevent late VKDB. Intramuscular administration is the unequivocal standard of care endorsed by the AAP and ACNM.
2. Ophthalmic Erythromycin Ointment Prophylaxis
- Clinical Objective: Universal ocular prophylaxis to prevent Ophthalmia Neonatorum (neonatal keratoconjunctivitis) caused by exposure to maternal cervicovaginal Neisseria gonorrhoeae during vaginal or cesarean delivery.
- Administration: A 1 cm ribbon of 0.5% erythromycin ophthalmic ointment instilled into each lower conjunctival sac within 1 to 2 hours of birth. The medication should not be flushed from the eyes.
- Critical Board Distinction: Erythromycin ophthalmic ointment is highly effective against N. gonorrhoeae (which can cause rapid corneal ulceration, globe perforation, and irreversible blindness within 24 to 48 hours), but it DOES NOT prevent neonatal chlamydial conjunctivitis caused by Chlamydia trachomatis. Chlamydial ophthalmia manifests later (5 to 14 days of life) and requires systemic oral macrolide therapy (erythromycin or azithromycin) to cure ocular infection and clear nasopharyngeal colonization, thereby preventing chlamydial interstitial pneumonitis.
3. Hepatitis B Virus (HBV) Immunoprophylaxis
Vertical transmission of hepatitis B from mother to infant carries a >90% risk of chronic lifelong HBV infection, cirrhosis, and hepatocellular carcinoma. Prevention relies on timely immunization based on maternal Hepatitis B surface Antigen (HBsAg) status:
| Maternal HBsAg Status | Required Neonatal Interventions & Timing | Midwifery Administration Protocols |
|---|---|---|
| HBsAg-Negative Mother | Monovalent Hepatitis B Vaccine (5 mcg / 0.5 mL IM) within 24 hours of birth | Administer IM in the anterolateral vastus lateralis. (If medically unstable or birth weight <2,000 g, vaccine may be deferred until hospital discharge or 1 month of age). |
| HBsAg-Positive Mother | Hepatitis B Vaccine (5 mcg IM) PLUS Hepatitis B Immune Globulin (HBIG 0.5 mL IM) | Administer both within 12 hours of birth at two separate anatomical injection sites (e.g., right and left thighs). Prevents vertical transmission in >95% of exposed infants. Post-vaccination serology (anti-HBs and HBsAg) is obtained at 9 to 12 months. |
| HBsAg Unknown Mother | Hepatitis B Vaccine within 12 hours of birth | Draw maternal blood stat to determine HBsAg status. If mother tests positive, administer HBIG as soon as possible, no later than day 7 of life (for term infants ≥2,000 g). If infant is preterm/low birth weight (<2,000 g), administer HBIG within 12 hours without awaiting lab results. |
Parents decline intramuscular vitamin K for their term breastfed newborn and ask about the oral alternative. Which counseling point is most important?